Biallelic pathogenic variants in SMN1 lead to spinal muscular atrophy (SMA), a progressive neurodegenerative disorder characterized by muscle weakness and atrophy resulting from the loss of motor neurons in the spinal cord37. Here, SMN1 is linked to proximal spinal muscular atrophy.